Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

[1]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[2]  A. Feldman,et al.  DUSP22 AND TP63 REARRANGEMENTS PREDICT OUTCOME OF ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A DANISH COHORT STUDY , 2017, Blood.

[3]  A. Feldman,et al.  DUSP22 AND TP63 REARRANGEMENTS PREDICT OUTCOME OF ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A DANISH COHORT STUDY , 2017 .

[4]  A. Rosenwald,et al.  Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. , 2017 .

[5]  T. Miyamoto,et al.  Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study , 2017, Bone Marrow Transplantation.

[6]  J. Gribben,et al.  Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[8]  Ambuj Kumar,et al.  Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  Wen-Qi Jiang,et al.  Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma , 2015, Scientific Reports.

[10]  Y. Oki,et al.  Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Cheong,et al.  Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  D. Schatz,et al.  Genomic landscape of cutaneous T cell lymphoma , 2015, Nature Genetics.

[13]  K. Savage,et al.  Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  N. Schmitz,et al.  Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Ishitsuka,et al.  Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. , 2014, The Lancet. Oncology.

[16]  N. Schmitz,et al.  Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party , 2014, Leukemia.

[17]  M. Kharfan-Dabaja,et al.  Umbilical cord blood transplantation induces a durable remission in hepatosplenic gamma‐delta T cell lymphoma with associated hemophagocytic lymphohistiocytosis , 2014, American journal of hematology.

[18]  W. Wilson,et al.  ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. , 2014, Blood.

[19]  L. Koh,et al.  Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group , 2014, Bone Marrow Transplantation.

[20]  S. Horwitz,et al.  How I treat the peripheral T-cell lymphomas. , 2014, Blood.

[21]  M. Taniwaki,et al.  Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Yin,et al.  Autologous Stem Cell Transplantation as the First-Line Treatment for Peripheral T Cell Lymphoma: Results of a Comprehensive Meta-Analysis , 2013, Acta Haematologica.

[23]  S. Montoto,et al.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  David Rind,et al.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. , 2013, Journal of clinical epidemiology.

[25]  G. Salles,et al.  Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. , 2013, Blood.

[26]  P. Gaulard,et al.  Molecular underpinning of extranodal NK/T-cell lymphoma. , 2013, Best practice & research. Clinical haematology.

[27]  K. Akashi,et al.  Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. , 2012, Blood.

[28]  J. Delabie,et al.  Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Advani,et al.  Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  R. Ueda,et al.  Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  S. Montoto,et al.  Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Suzuki,et al.  Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Li,et al.  Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma , 2011, Medical oncology.

[34]  E. D. Jacobsen,et al.  A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  S. Steinberg,et al.  Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. , 2011, Blood.

[36]  K. Savage,et al.  Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  S. Forman,et al.  Reduced Intensity Allogeneic Hematopoietic Cell Transplantation using Fludarabine-Melphalan conditioning for Treatment of Mature T-cell Lymphomas , 2011, Bone Marrow Transplantation.

[38]  A. Rosenwald,et al.  Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. , 2010, Blood.

[39]  N. Schmitz,et al.  Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A. Bazarbachi,et al.  Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  K. Matsuo,et al.  Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. , 2010, Blood.

[42]  S. Proctor,et al.  Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. , 2010, Blood.

[43]  K. Ohshima,et al.  Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  N. Schmitz,et al.  Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  R. Hoppe,et al.  A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[46]  Jeeyun Lee,et al.  Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[47]  D. Weisenburger,et al.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  F. Awan,et al.  Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[49]  G. Guyatt,et al.  A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. , 2008, The Journal of clinical endocrinology and metabolism.

[50]  N. Schmitz,et al.  Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma , 2008, Bone Marrow Transplantation.

[51]  R. Ueda,et al.  VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  T. Barbui,et al.  Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation , 2006, Leukemia.

[53]  A. Bosi,et al.  Allogeneic stem cell transplantation. , 2005, Transplantation proceedings.

[54]  Yeon-Hee Park,et al.  High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma , 2005, Leukemia & lymphoma.

[55]  S. Sacchi,et al.  Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas , 2004, Cancer.

[56]  R. Gascoyne,et al.  Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[57]  E. Iannitto,et al.  Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. , 2004, Blood.

[58]  W. Au,et al.  Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  T. Molina,et al.  Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  L. Ross,et al.  Are doctors altruistic? , 2002, Journal of medical ethics.

[61]  S. Whittaker,et al.  Autologous Peripheral Blood Stem Cell Transplantation in Tumor‐stage Mycosis Fungoides: Predictors of Disease‐free Survival , 2001, Annals of the New York Academy of Sciences.

[62]  M. Duvic,et al.  Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  P. Gaulard,et al.  Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). , 1998, Blood.

[64]  K. Thomsen,et al.  T‐cell receptor γδ‐positive peripheral T‐cell lymphomas presenting in the skin: , 1992 .

[65]  A. Utsunomiya.  Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma. , 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[66]  A. Nagler,et al.  Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP , 2014, Bone Marrow Transplantation.

[67]  Gerald Gartlehner,et al.  [GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[68]  N. Schmitz,et al.  Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  B. Thiers.  Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma , 2008 .

[70]  N. Schmitz,et al.  Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study. , 2004, The hematology journal : the official journal of the European Haematology Association.

[71]  Y. Kodera,et al.  Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation , 2001, Bone Marrow Transplantation.

[72]  M. Tomonaga,et al.  Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature , 1999, Bone Marrow Transplantation.

[73]  L. Brady,et al.  Autologous bone marrow transplantation for advanced stage mycosis fungoides. , 1991, Bone marrow transplantation.